FindTrial
Sign In

Therapeutic mechanism of different subtypes of polycystic ovary syndrome by intestinal flora-endocrine axis

Effects of different TCM syndromes on the structure of inflammatory immune molecules and intestinal flora in patients based on the

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017930
Enrollment
Unknown
Registered
2018-08-22
Start date
2018-08-30
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovarian syndrome, PCOS

Interventions

Case series:Taking Chinese medicine

Sponsors

Guangdong Provincial Hospital of Traditional Chinese Medicine Ersha Branch Laboratory
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: met the diagnostic criteria of Western medicine PCOS disease; did not use any hormonal drugs within 3 months; the selected volunteers were all without antibiotics, probiotics or immunosuppressants within 4 weeks before sampling, no enteritis, acute and chronic gastrointestinal tract Disease, autoimmune disease, etc., no history of surgery. The compliance was good, and the selected volunteers had a detailed understanding of the sampling process and research purposes before sampling, and signed informed consent.

Exclusion criteria

Exclusion criteria: Thyroid dysfunction; hyperprolactinemia; delayed type adrenal hyperplasia; Cushing's syndrome; primary ovarian dysfunction or premature ovarian failure; ovarian or adrenal gland secretion of androgen tumor; functional hypothalamic amenorrhea.

Design outcomes

Primary

MeasureTime frame
Intestinal flora;—

Countries

China

Contacts

Public ContactJianhua Xu

Guangdong Provincial Hospital of Traditional Chinese Medicine

jhxu1976@126.com+86 13719287909

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026